We are live on
!
Find out more
PCM
Piermont Capital Management Portfolio holdings
AUM
$211M
1-Year Est. Return
8.09%
This Fund
S&P 500
This Quarter
Est. Return
+7.52%
1 Year Est. Return
-8.09%
3 Year Est. Return
+33.18%
5 Year Est. Return
+53.13%
10 Year Est. Return
–
AUM
$422M
AUM Growth
+$36M
(+9.3%)
Cap. Flow
+$16.2M
Cap. Flow
% of AUM
3.84%
Top 10 Holdings %
Top 10 Hldgs %
10%
Holding
310
New
74
Increased
75
Reduced
64
Closed
65
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Murphy USA
MUSA
|
+$3.73M |
| 2 |
Spire
SR
|
+$3.35M |
| 3 |
Strategy Inc
MSTR
|
+$3.32M |
| 4 |
Interface
TILE
|
+$3.31M |
| 5 |
RPT
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
|
+$3.18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALE
Allete
ALE
|
+$3.98M |
| 2 |
Sanmina
SANM
|
+$3.55M |
| 3 |
Portland General Electric
POR
|
+$3.55M |
| 4 |
Trustmark
TRMK
|
+$3.48M |
| 5 |
Northwest Natural Holdings
NWN
|
+$3.37M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.89% |
| 2 | Industrials | 17.05% |
| 3 | Technology | 12.96% |
| 4 | Consumer Discretionary | 12.85% |
| 5 | Real Estate | 9.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CIT
201
DELISTED
CIT Group Inc.
CIT
| $668K | 0.16% |
18,415
| – | – |
|
202
Graco
GGG
$13.5B
| $666K | 0.16% |
+27,000
| New | +$675K |
|
203
Factset
FDS
$10.2B
| $663K | 0.16% |
4,090
| – | – |
|
|
BIG
204
DELISTED
Big Lots, Inc.
BIG
| $657K | 0.16% |
13,750
| – | – |
|
205
CubeSmart
CUBE
$9.41B
| $646K | 0.15% |
+23,710
| New | +$680K |
|
|
EXPR
206
DELISTED
Express, Inc.
EXPR
| $643K | 0.15% |
2,727
+244
| +10% | +$66.1K |
|
207
Lexicon Pharmaceuticals
LXRX
$1.1B
| $642K | 0.15% |
+35,540
| New | +$572K |
|
208
Vanda Pharmaceuticals
VNDA
$302M
| $641K | 0.15% |
+38,540
| New | +$519K |
|
209
First Financial Corp
THFF
$969M
| $640K | 0.15% |
+15,732
| New | +$621K |
|
|
WCG
210
DELISTED
Wellcare Health Plans, Inc.
WCG
| $640K | 0.15% |
+5,470
| New | +$611K |
|
|
SIX
211
DELISTED
Six Flags Entertainment Corp.
SIX
| $636K | 0.15% |
11,870
| – | – |
|
212
Fortinet
FTNT
$117B
| $631K | 0.15% |
+85,400
| New | +$597K |
|
213
Encompass Health
EHC
$12.4B
| $630K | 0.15% |
19,534
| – | – |
|
|
CVG
214
DELISTED
Convergys
CVG
| $629K | 0.15% |
+20,670
| New | +$586K |
|
|
TCO
215
DELISTED
Taubman Centers Inc.
TCO
| $627K | 0.15% |
+8,420
| New | +$650K |
|
216
Agios Pharmaceuticals
AGIO
$1.93B
| $625K | 0.15% |
+11,830
| New | +$515K |
|
|
CMD
217
DELISTED
Cantel Medical Corporation
CMD
| $625K | 0.15% |
8,010
| – | – |
|
218
Alaska Air
ALK
$5.58B
| $624K | 0.15% |
9,480
| – | – |
|
219
Casey's General Stores
CASY
$30.9B
| $624K | 0.15% |
+5,190
| New | +$668K |
|
220
Hasbro
HAS
$13.2B
| $624K | 0.15% |
7,860
| – | – |
|
|
AL
221
DELISTED
Air Lease Corp
AL
| $623K | 0.15% |
21,800
+3,210
| +17% | +$91K |
|
222
Xencor
XNCR
$1.55B
| $615K | 0.15% |
+25,103
| New | +$531K |
|
223
Ciena
CIEN
$58.4B
| $606K | 0.14% |
27,790
| – | – |
|
224
NewMarket
NEU
$8.18B
| $597K | 0.14% |
+1,390
| New | +$592K |
|
225
Celanese
CE
$4.82B
| $594K | 0.14% |
8,930
| – | – |
|
Similar funds
WAM
GIM
PPC
MA
PC
HCG
WA
VAM
Piermont Capital Management's Q3 2016 Portfolio in Review
As of Q3 2016, Piermont Capital Management held 310 positions worth $422M, up 9.3% from $386M the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Piermont Capital Management deployed $16.2M of net new capital in Q3 2016, opening 74 new positions and adding to 75 existing holdings. Its largest new stake was Murphy USA: 49,881 shares worth $3.56M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Anika Therapeutics, an estimated $1.15M trimmed.
- Piermont Capital Management's largest Q3 2016 buy was Murphy USA: 49,881 shares worth $3.56M.
- Piermont Capital Management added most to Spire in Q3 2016, an estimated $3.35M increase.
- Piermont Capital Management's biggest Q3 2016 reduction was Anika Therapeutics, cutting an estimated $1.15M.
- Piermont Capital Management fully exited Allete in Q3 2016, selling an estimated $3.98M.
- Piermont Capital Management's ten largest holdings make up 10% of its $422M portfolio in Q3 2016.
- Piermont Capital Management opened 74 new positions and closed 65 in Q3 2016.
- Piermont Capital Management's portfolio value rose 9.3% quarter-over-quarter to $422M.
Based on Piermont Capital Management's 13F filing for Q3 2016, filed 10 Nov 2016.